Michael Pacanowski

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Acute pain pathways: protocol for a prospective cohort study”.

Acute pain pathways: protocol for a prospective cohort study

BMJ Open(2022)10.1136/bmjopen-2021-058782

N/A

0.363DataRank · unranked

7 citations

Mitra Ahadpour, Summer V. Allen, Richardae Araojo, Fernanda Bellolio, Nancy Chang +25 more

Acute Pain Pathways: protocol for a prospective cohort study

medRxiv(2021)10.1101/2021.10.21.21265156

N/A

0DataRank · unranked

1 citations

Mitra Ahadpour, Summer V. Allen, Richardae Araojo, Fernanda Bellolio, Nancy Chang +25 more

A Multistakeholder Perspective on Advancing Individualized Therapeutics

Clinical Pharmacology & Therapeutics(2023)10.1002/cpt.3030

N/A

0DataRank · unranked

4 citations

Julia Vitarello, Insoo Hyun, Timothy W. Yu, Issam Zineh, Michael Pacanowski

Clinical pharmacology considerations for first‐in‐human clinical trials for enzyme replacement therapy

Journal of Inherited Metabolic Disease(2024)10.1002/jimd.12746

N/A

0DataRank · unranked

4 citations

Jie Wang, Ruo‐Jing Li, Yuen Yi Hon, Shawna L. Weis, Yow‐Ming Wang +3 more

Assessment of Dosing Strategies for Pediatric Drug Products

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3250

N/A

0DataRank · unranked

6 citations

Francis G. Green, Nayeem Hossain, Gilbert J. Burckart, Michael Pacanowski, Robert N. Schuck +1 more

FDA Approval Summary: Capecitabine Labeling Update under Project Renewal

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1708

N/A

0DataRank · unranked

3 citations

C S Lee, William F. Pierce, Elizabeth Everhart, Adriene King-Ducre, Melanie Royce +13 more

Leveraging in Vitro Models for Clinically Relevant Rare CYP2D6 Variants in Pharmacogenomics

Drug Metabolism and Disposition(2024)10.1124/dmd.123.001512

N/A

0DataRank · unranked

1 citations

Paula L. Hyland, Michael Pacanowski, Robert N. Schuck, Sydney Stern

Trends in clinical studies evaluating neurofilament light chain as a biomarker

Biomarkers in Medicine(2025)10.1080/17520363.2025.2562546

N/A

0DataRank · unranked

2 citations

Kristin M. Miner, Sreedharan Sabarinath, Shawna L. Weis, Robert N. Schuck, Michael Pacanowski +1 more

Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2131

N/A

0DataRank · unranked

13 citations

T. Mark Beasley, Jielin Sun, Norman Stockbridge, Michael Pacanowski, Jeffry Florian +1 more

The Evaluation of Interactions Between Multiple Intrinsic and Extrinsic Factors Reported in Labeling for FDA‐Approved Drugs

The Journal of Clinical Pharmacology(2025)10.1002/jcph.70064

N/A

0DataRank · unranked

0 citations

Sydney Stern, Elyes Dahmane, Anuradha Ramamoorthy, Michael Pacanowski, Robert N. Schuck +1 more